Search for: "Novartis Pharmaceuticals Corporation" Results 61 - 80 of 156
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jun 2010, 6:47 am by Andrew Frisch
In its brief, the DOL argues that the district court in that case committed legal error when it concluded that the pharmaceutical sales representatives employed by Novartis Pharmaceutical Corporation (“NPC”) were exempt from the overtime requirements of the FLSA under the outsides sales and administrative exemptions. [read post]
11 Feb 2008, 9:20 am
February 2008 Australian Report Links Liver Failure And Hepatitis To Popular Novartis Drug (Posted by Tom Lamb at DrugInjuryWatch.com) A February 4, 2008 article, "Anti-fungal tablet linked to liver deaths", published by Australia's Herald Sun newspaper, brought to our attention the fact that Australian drug regulators have issued a warning about serious liver reactions after taking a popular prescription drug used to treat fungal infections, Lamisil (terbinafine),… [read post]
29 Oct 2019, 10:48 am by Jeffrey A. Newman
Braun Medical Inc.; Forest Laboratories, Inc.; GlaxoSmithKline LLC; Johnson & Johnson, Inc.; Janssen Pharmaceutical Products, LP; McNeil-PPC, Inc.; Ortho Biotech Products, LP; Ortho-McNeil Pharmaceutical, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Pharmacia Corporation; and TAP Pharmaceutical Products, Inc. [read post]
1 Aug 2012, 7:04 pm
In this case, Novartis Pharmaceuticals Corporation sales representatives in 2006 claim that they were denied overtime pay which is a violation of the Fair Labor Standards Act. [read post]
15 Sep 2015, 2:20 pm by Tom Lamb
This September 2015 Drug Safety Alert Is Based Primarily On Reports Of Skin Cancer And Lymphoma Blood Cancer &nbsp (Posted by Tom Lamb at DrugInjuryWatch.com)   Health Canada recently conducted a review of safety information obtained from the drug company Novartis Pharmaceuticals Corporation, the manufacturer of Gilenya (fingolimod), about a potential link between the use of this multiple sclerosis (MS) drug and certain types of cancers and malignant tumors or… [read post]
17 Feb 2011, 1:59 pm by AALRR
SmithKline Beecham Corporation (“Glaxo”) hired plaintiffs in 2003 to meet with physicians and encourage them to prescribe Glaxo pharmaceuticals.  [read post]
25 Nov 2011, 5:00 am by Bexis
Novartis Pharmaceuticals Corp., 2011 WL 5835414, slip op. [read post]
30 Dec 2012, 3:30 am by Gene Quinn & Angel Krippner
On October 31, 2012, Acacia Research Corporation (Nasdaq:ACTG) announced that its subsidiaries... [read post]
2 Mar 2010, 6:28 am by John J. Cord
Up until now, online social networking has been treated mostly as a plaything for some pharmaceutical manufacturers. [read post]
26 Mar 2011, 10:17 am
It is another in a spate of gender discrimination lawsuits filed recently against large corporations: last Monday a class action lawsuit was filed against Bayer HealthCare Pharmaceuticals and its parent, Bayer Corp., both U.S. units of Bayer AG, alleging the company has engaged in various discriminatory behaviors against its female employees. (1) The lawsuit, filed in U.S. [read post]
25 Aug 2010, 7:37 am by Levin & Perconti
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
3 May 2013, 6:33 pm by Swaraj Paul Barooah
One can hope that (while certainly corporations are people too), this '... for the people' government is trying to sort out their own (non-corporation) people's medical problems with the same vigour, for, at last check, they were still having plenty of issues with medical bills. [read post]
30 Aug 2009, 10:00 pm
Bivins (a citizen of Texas) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. [read post]
15 Oct 2008, 8:38 am
"In effect the Bush administration made the safety of Americans secondary to corporate profits. [read post]
27 Sep 2010, 12:59 am by FDABlog HPM
Karst –    Just two days after Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]